United Therapeutics Corporation (UTHR)
Days of inventory on hand (DOH)
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Inventory turnover | 1.96 | 2.08 | 2.14 | 2.31 | 2.30 | 2.32 | 2.03 | 1.71 | 1.46 | 1.40 | 1.31 | 1.42 | 1.31 | 1.27 | 1.32 | 1.17 | 1.25 | 1.16 | 1.24 | 1.22 | |
DOH | days | 186.09 | 175.67 | 170.74 | 157.76 | 158.47 | 157.05 | 179.97 | 213.66 | 250.37 | 260.71 | 278.32 | 256.72 | 279.49 | 287.66 | 275.74 | 312.47 | 292.07 | 314.24 | 294.69 | 300.09 |
December 31, 2024 calculation
DOH = 365 ÷ Inventory turnover
= 365 ÷ 1.96
= 186.09
United Therapeutics Corporation's days of inventory on hand (DOH) has shown fluctuations over the past few years. The company experienced a peak DOH of 314.24 days on September 30, 2020, indicating a longer period to sell through its inventory. Subsequently, there was a gradual decline in DOH, reaching a low of 157.05 days on September 30, 2023, suggesting a more efficient management of inventory levels.
However, there was a slight increase in DOH to 186.09 days on December 31, 2024, indicating a potential buildup of inventory. Overall, it is important for United Therapeutics to closely monitor its inventory management practices to ensure optimal levels that support operational efficiency and profitability.
Peer comparison
Dec 31, 2024